Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $5.80M.
ENTERPRISE VALUE (EV)
$5.80M
Adial Pharmaceuticals, Inc.
Market Cap
$11.69M
Enterprise Value (EV)
$5.80M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | $11.69M | $5.80M |
| Biofrontera Inc. (BFRI)vs › | $11.55M | $14.40M |
| Pluri Inc. (PLUR)vs › | $11.54M | $42.93M |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.84M | $5.01M |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.44M | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | $4.56M |
| BioVie Inc. (BIVI)vs › | $11.12M | $2.42M |
| Cerenome, Inc. (CNSY)vs › | $11.08M | $8.76M |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.84M | $393604.00 |
| Dare Bioscience, Inc. (DARE)vs › | $12.54M | $6.69M |
Market Cap
$11.69M
Total Debt
$0.00
Cash
$5.88M
Enterprise Value
$5.80M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
